1350 S. LOOP ROAD, ALAMEDA, CA
Announces Pricing of Common Stock Offering
Provides Business Update and Reports Third Quarter 2025 Financial Results
Withdraws Record Date for Neuromodulation Subsidiary Spin-Off
Announces Record Date for Spin-off of Neuromodulation Subsidiary to Shareholders
Reg. FD
Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management
Investor Presentation
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
SEC Form 25 - Delisting Notification
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence
Submission Upload